Prospective cohort study demonstrates treatment improves cardiopulmonary function in beta thalassemia patients with pulmonary hypertension, indicating better management strategies are necessary.
Repeated blood transfusions correlate with RV dysfunction in thalassaemia patients with PH. Vasodilatory treatment improves 6MWT, proBNP levels, and E/e' ratio, indicating RV function enhancement. This study underscores the importance of comprehensive management strategies for thalassaemia patients with PH to mitigate associated complications and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Moghadas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: